BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6469754)

  • 1. Pharmacokinetic studies of amino acid analogues of 2-nitroimidazole, new hypoxic cell radiosensitizers.
    Agrawal KC; Larroquette CA; Garg PK
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1301-5. PubMed ID: 6469754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC; Rupp WD; Rockwell S
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Fluorobenzylamine and phenylalanine methyl ester conjugates of 2-nitroimidazole: evaluation as hypoxic cell radiosensitizers.
    Garg PK; Garg S; Degraff WG; Zalutsky MR; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1992; 22(3):593-6. PubMed ID: 1531220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential radiosensitizing agents. 7. 4(5)-Iodo-5(4)-nitroimidazole derivatives.
    Gupta RP; Larroquette CA; Agrawal KC; Grodkowski J; Neta P
    J Med Chem; 1985 Aug; 28(8):987-91. PubMed ID: 4020837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as cytotoxin and radiosensitizer.
    Papadopoulou MV; Ji M; Rao MK; Bloomer WD
    Oncol Res; 1996; 8(10-11):425-34. PubMed ID: 9114435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential radiosensitizing agents. 4. 2-Nitroimidazole nucleosides.
    Sakaguchi M; Webb MW; Agrawal KC
    J Med Chem; 1982 Nov; 25(11):1339-42. PubMed ID: 6890579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitro.
    Stratford IJ; Williamson C; Hardy C
    Br J Cancer; 1981 Jul; 44(1):109-16. PubMed ID: 7259957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione depletion by 2-nitroimidazole-1-acetohydroxamic acid as a radiosensitizer in hypoxic rat hepatocytes.
    Takanuki K; Igarashi T; Hata K; Hori H; Shibata T; Kitagawa H; Satoh T; Inayama S
    Biochem Int; 1988 Jul; 17(1):155-62. PubMed ID: 3190713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new ruthenium radiosensitizer: RuCl2(DMSO)2(4-nitroimidazole)2.
    Chan PK; Skov KA; James BR; Farrell NP
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1059-62. PubMed ID: 3744927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of extracellular pH on radiosensitization by misonidazole and acidic or basic analogues.
    Watts ME; Jones NR
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):645-53. PubMed ID: 3873434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential radiosensitizing agents. 6. 2-Nitroimidazole nucleosides: arabinofuranosyl and hexopyranosyl analogues.
    Sakaguchi M; Larroquette CA; Agrawal KC
    J Med Chem; 1983 Jan; 26(1):20-4. PubMed ID: 6827525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
    Ahmed I; Stratford IJ; Jenkins TC
    Arzneimittelforschung; 1985; 35(12):1763-8. PubMed ID: 4096727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds.
    Papadopoulou MV; Epperly MW; Shields DS; Bloomer WD
    Jpn J Cancer Res; 1992 Apr; 83(4):410-4. PubMed ID: 1506276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer.
    Hori H; Murayama C; Mori T; Shibamoto Y; Abe M; Onoyama Y; Inayama S
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1029-32. PubMed ID: 2703381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake of misonidazole and analogues with acidic or basic functions.
    Dennis MF; Stratford MR; Wardman P; Watts ME
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):629-43. PubMed ID: 3873433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
    Palcic B; Faddegon B; Skarsgard LD
    Radiat Res; 1984 Nov; 100(2):340-7. PubMed ID: 6494445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides.
    Bonnet M; Hong CR; Wong WW; Liew LP; Shome A; Wang J; Gu Y; Stevenson RJ; Qi W; Anderson RF; Pruijn FB; Wilson WR; Jamieson SMF; Hicks KO; Hay MP
    J Med Chem; 2018 Feb; 61(3):1241-1254. PubMed ID: 29253343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies on toxic and radiosensitizing properties of ruthenium complexes of 4-nitroimidazoles.
    Chan PK; Skov KA; James BR
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):49-55. PubMed ID: 3496310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
    Astor M; Hall EJ
    Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.